Tollovid

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Data from Tollovid Study

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Data from Tollovid Study Read More »

Breaking News: Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing IRB-waived sponsored market research study of the commercial use of Tollovid® as a dietary supplement. Among the first 41 respondents, of whom 78% were fully vaccinated against COVID-19, 13 …

Breaking News: Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) New FDA Certificate for Tollovid

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) New FDA Certificate for Tollovid Read More »

Breaking News: Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received a new certificate of free sale (CFS) from the US Food & Drug Administration whose label provides for both a 5-day support dosing regimen and a 30-day maintenance dosing regimen of Tollovid® …

Breaking News: Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Market Research Study & 50% Price Reduction

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received an Institutional …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Market Research Study & 50% Price Reduction Read More »

Breaking News: Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received an Institutional Review Board (IRB) waiver to initiate a market research study to gather and evaluate consumer feedback regarding the use of the Company’s 3CL protease inhibitor immune support dietary supplement products …

Breaking News: Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022 Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovid COVID Case Study

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovid COVID Case Study Read More »

Breaking News: Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. is reporting a case study from Dr. Lee Morgentaler of a patient who used Tollovid®, the Company’s 3CL protease inhibitor dietary supplement immune support product, after experiencing Long COVID symptoms. Concurrent with this report, …

Breaking News: Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study Read More »

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovid Informed Sport Certification

Biotechnology, Breaking News, Buzz On The Street, Healthcare, Investing News, Market News, Technology, The Buzz TV, The Market Buzz, Top Videos, Video

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group.” Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport Certification for Tollovid®, the Company’s …

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Tollovid Informed Sport Certification Read More »

Breaking News: Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group

Biotechnology, Breaking News, Healthcare, Investing News, Market News, Technology, The Market Buzz

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport Certification for Tollovid®, the Company’s proprietary 3CL protease inhibitor dietary supplement product currently for sale on Amazon, MyTollovid.com and at The Alchemist’s Kitchen in New York City. “We have heard from many elite athletes looking …

Breaking News: Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC Group Read More »

Stay Connected

Twitter Linkedin-in Instagram Facebook-f Youtube

Subscribe

Subscribe
Subscribe